Clinical Trial: Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417670) titled 'Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease' on Feb. 11.

Brief Summary: The goal of this clinical study is to evaluate satisfaction with the use of orodispersible Memantine (OD) versus conventional Memantine tablets (MTb) using the validate SATMED-Q in patients with moderate to severe Alzheimer's disease. Due to the neurocognitive impairment associated with these stages of the disease, treatment satisfaction will be assessed indirectly through the primary caregiver.

The main questions this study seeks to answer are:

* Is caregiver satisfaction higher with OD (Sinolvir(R)) co...